RecruitingNCT05548621

A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)


Sponsor

St. Antonius Hospital

Enrollment

180 participants

Start Date

Nov 24, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study is to evaluate the effect of two decision aids for renal cell carcinoma (RCC) on the decision-making process and the quality of the decision.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how well a "shared decision-making" approach works in practice for people with kidney cancer (renal cell carcinoma). Shared decision-making means the patient and doctor work together using special tools to choose the best treatment option. **You may be eligible if...** - You have been diagnosed with kidney cancer (renal cell carcinoma) - You are facing a treatment decision about a small early-stage tumor or advanced/metastatic disease - You have provided written informed consent **You may NOT be eligible if...** - You are unable to complete questionnaires or participate in an individual interview Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDecision aid

Online interactive decision aid for RCC


Locations(1)

St. Antonius Ziekenhuis

Nieuwegein, Utrecht, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05548621


Related Trials